Szukasz tirzepatide w Polsce? Oto, jak wygląda dostęp w UK

You searched in Polish, here is the situation you are probably in

Perhaps you used tirzepatide back in Poland, or a family member told you about it, or you simply searched in your first language out of habit. Whatever the reason, this page is for you if you are now living in the UK and want to understand how access works here.

In the UK, tirzepatide is licensed under the brand name Mounjaro. It comes as a once-weekly injection using a pre-filled KwikPen. You do not collect it from a GP surgery; you obtain it through a private prescription from a registered prescriber, or (if you meet strict NHS criteria) through an NHS pathway that currently has significant waiting lists for most people. The private route is faster, and it starts with a clinical consultation rather than a referral queue.

The key thing to understand is that the medicine itself is identical wherever you are in Europe, the active ingredient is tirzepatide, the doses run from 2.5 mg up to 15 mg, and it works by activating two gut-hormone receptors (GIP and GLP-1) that reduce appetite and slow gastric emptying. What differs country to country is who can prescribe it, through which pharmacy you can get it, and what legal safeguards protect you as a patient. In the UK those safeguards are managed by the MHRA and the GPhC. You can read more about how tirzepatide works and what to expect if this is your first time considering it.

One practical note our prescribers hear often from patients who have used it abroad: the pen goes in the fridge door when you get home, just as it did in Poland. Storage requirements are the same (2 to 8°C) and the Patient Information Leaflet tells you the exact window if it ever needs to be kept at room temperature.

Why buying tirzepatide from outside the UK is not the safe shortcut it looks like

It is tempting to think you can order from a Polish or European online pharmacy and save yourself the steps. In practice this is both legally complicated and genuinely risky. Importing prescription medicines for personal use from another country falls outside normal consumer protections, and you have no reliable way to confirm the product is genuine, stored correctly, or dispensed against a valid prescription.

The MHRA has been explicit about the danger. Since 2023 it has seized large quantities of fake weight-loss pens circulating online, including counterfeit tirzepatide pens, some containing harmful substances. Its public guidance (the Yellow Card reporting scheme also covers suspect sellers) makes clear that the only safe route is a pharmacy you can verify on the GPhC register. Sellers offering these medicines without a valid prescription, at prices far below the UK market, or via social media, are serious red flags regardless of what country they claim to be based in.

Verifying a UK pharmacy takes about thirty seconds at the GPhC register. If the pharmacy is not listed, do not order from them. That applies to any online seller, wherever they are based.

If you are considering the cost side of things, the UK pricing landscape for Mounjaro explains what a legitimate private prescription typically costs and why the cheapest listing is usually the wrong thing to optimise for.

How eligibility works in the UK and what the consultation covers

UK eligibility for Mounjaro on a private prescription follows the licensed criteria from the SmPC: adults with a BMI of 30 or above, or 27 or above if there is at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI alone is not the whole picture; a prescriber reviews your full health history, any medicines you already take, and whether there are any reasons the treatment would not be appropriate for you.

NICE's appraisal of tirzepatide, TA1026 published in December 2024, sets out the NHS-specific criteria, which are stricter (BMI 35 or above plus weight-related comorbidities). The private prescribing criteria are broader and based directly on the licensed indication. Neither route is a formality, a real prescriber makes the call.

If you were already on tirzepatide before arriving in the UK and want to continue at your current dose, a prescriber at a UK pharmacy will need to see evidence of your existing treatment, and if you are continuing from a lower maintenance dose you can find more detail on what tirzepatide l covers and how that dose category is used here. You can explore what Mounjaro treatment through a UK pharmacy involves, or read about how Mounjaro and tirzepatide relate to each other if the two names have caused any confusion.

For a broader look at weight-loss treatment options available in the UK, that page covers what is licensed and how different medicines compare. When you are ready, you can start a free consultation and a GPhC-registered prescriber will review your details the same day, including whether a higher maintenance strength such as tirzepatide 30 is relevant to where you are in your treatment.